Surfaces with instant and persistent antimicrobial efficacy against bacteria and SARS-CoV-2
- PMID: 36034972
- PMCID: PMC9399129
- DOI: 10.1016/j.matt.2022.08.018
Surfaces with instant and persistent antimicrobial efficacy against bacteria and SARS-CoV-2
Abstract
Surfaces contaminated with bacteria and viruses contribute to the transmission of infectious diseases and pose a significant threat to global public health. Modern day disinfection either relies on fast-acting (>3-log reduction within a few minutes), yet impermanent, liquid-, vapor-, or radiation-based disinfection techniques, or long-lasting, but slower-acting, passive antimicrobial surfaces based on heavy metal surfaces, or metallic nanoparticles. There is currently no surface that provides instant and persistent antimicrobial efficacy against a broad spectrum of bacteria and viruses. In this work, we describe a class of extremely durable antimicrobial surfaces incorporating different plant secondary metabolites that are capable of rapid disinfection (>4-log reduction) of current and emerging pathogens within minutes, while maintaining persistent efficacy over several months and under significant environmental duress. We also show that these surfaces can be readily applied onto a variety of desired substrates or devices via simple application techniques such as spray, flow, or brush coating.
Keywords: COVID-19; SARS-COV-2; antimicrobial; antiviral; durable; gram-negative; gram-positive; instant kill; long-lasting; persistent.
© 2022 Elsevier Inc.
Conflict of interest statement
The University of Michigan has applied for a patent based on this technology. A startup company HygraTek LLC has licensed this technology from the University of Michigan. A.T. has equity and has been a paid consultant, for HygraTek LLC.
Figures
References
-
- Page K., Wilson M., Parkin I.P. Antimicrobial surfaces and their potential in reducing the role of the inanimate environment in the incidence of hospital-acquired infections. J. Mater. Chem. 2009;19:3819–3831. doi: 10.1039/b818698g. - DOI
-
- Dantes R., Mu Y., Belflower R., Aragon D., Dumyati G., Harrison L.H., Lessa F.C., Lynfield R., Nadle J., Petit S., et al. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern. Med. 2013;173:1970–1978. doi: 10.1001/jamainternmed.2013.10423. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous